SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that ...
More than a month after filing for Chapter 11 bankruptcy, NanoString Technologies has agreed to be acquired by the healthcare investment firm Patient Square Capital for $220 million pending approval ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (OTC: NSTGQ) (“NanoString” or the “Company”), a leading provider of life science tools for discovery and translational research, today announced ...
NanoString is an Established Leader and Valuable Innovator in Gene Expression Profiling and Spatial Transcriptomics for Scientific and Clinical Research in Healthcare Under the asset purchase ...
NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Seattle-based publicly traded biotech company NanoString Technologies said in ...
NanoString, the Seattle-based biotech company that initiated a Chapter 11 bankruptcy process last month, announced late Sunday it agreed to a deal with healthcare investment firm Patient Square ...
Brad Gray talked to the Puget Sound Business Journal about how honing in on cancer diagnostics has already started to pay dividends. Seattle biotech NanoString Technologies (Nasdaq: NSTG) is finding ...